# Vital Farms share price today (Vital Farms, Inc., VITL)

> Vital Farms, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. VITL · Consumer Staples · Farm Products · data as of 4 November 2026. Page: https://www.sectoralpha.in/us/stocks/vitl

Sector Alpha also publishes a daily newsletter that explains one Indian stock at a time: https://newsletter.sectoralpha.in/?utm_source=sectoralpha&utm_medium=ai_text&utm_campaign=llms

## Key numbers

- Business trend: Getting worse, from the last 12 quarters
- Price: $10.50 (−69.7% in a year)
- P/E: 2,983.4×, over 1 year
- Revenue (Jun 2026): $166 M (−10.1% on a year ago)
- Profit (Jun 2026): −$31.1 M (−286.7% on a year ago)
- Operating margin: −24.2% (−37.1 points on a year ago)
- ROE: 19%, FY25
- ROIC: −8.0%, against a 8.0% cost of capital: −16.0 points

The main question: yearly earnings per share moved +22.0% while the share price moved −69.7%. ## What is the Vital Farms share price today? Vital Farms, Inc.'s share price was $10.50 at the close on 4 November 2026. That is 23.5% below its average price over the last 200 trading days. In the last 52 weeks it traded between $8 and $35, and at that close it sat 8% of the way up from that low. Over the past 13 weeks it has done worse than the S&P 500, and it has been behind for 7 weeks running. Over the last 1 year the share price moved −72% while the S&P 500 moved +23%, so it is behind the index over that whole period. It was last ahead over 13 weeks in the week of 18 September 2026. The chart above shows the 13-week comparison for every week. This page treats a rise as over when the price closes below its 200-day average on two Fridays in a row. ## What dividend does Vital Farms pay? Vital Farms, Inc. pays no dividend. In the last 12 reported quarters it declared no dividend per share, so there is no payout history to chart and no yield to show. Companies like this usually keep their earnings in the business, so the cash-flow sections show where that cash goes. ## Which stock lists is Vital Farms on? Vital Farms is not in the Nasdaq 100, the S&P 500 or the Dow Jones 30, and is not on the US tech stocks list. ## Is Vital Farms profitable? Vital Farms, Inc. posted a net loss of $31.1 M in the Jun 2026 quarter. Full-year FY25 profit was $66.3 M. Over 4 years profit has grown 128.6% a year on average. That loss is 18.7% of the quarter's revenue. The same quarter a year earlier earned $16.6 M. 2 of the last 12 reported quarters were loss-making. Jun 2026 profit was −$31.1 M, −286.7% on a year earlier. For the full year, FY25 profit was $66.3 M (+24.2% on the year before). Why profit moved: revenue changed −10.1% on a year earlier and the margin moved −37.1 percentage points. Sales did the work while the margin got thinner. On average over the last four quarters, profit changed −55.2% and revenue +17.8%. Profit is growing slower than sales: rising costs are taking part of the growth. ## How much revenue does Vital Farms make, and is it growing? Vital Farms, Inc. reported $166 M of revenue in the Jun 2026 quarter, −10.1% on the same quarter a year earlier. Over 4 years it has grown 30.6% a year on average. The last full year, FY25, came in at $759 M. The last four reported quarters add to $766 M. FY25 revenue was $759 M, +25.3% on the year before. Recent pace: the last four quarters grew +17.8% on average, against 30.6% a year over the longer run, so this year is growing slower than its own long-run rate. Is growth speeding up? Revenue over the last 12 months grew +16.4%, against +18.9% a year over the last 8 quarters (stabilising); profit over the last 12 months grew −99.7%, against −94.2% a year (rolling over). ## How much of every $100 of sales does Vital Farms keep? Vital Farms, Inc.'s operating margin was −24.2% in the Jun 2026 quarter, 37.1 percentage points lower than the same quarter a year ago. Its latest full-year margin is the highest it has ever reported. Across 5 years it has been between 0.0% and 11.6%. The latest quarter is below every full year in that period. Across 5 years it has been between 0.0% and 11.6%, and FY25's 11.6% is the highest of them. Why the margin moved: operating margin changed −37.1 percentage points on the year while gross margin changed −32.3 points. So the drop came mostly from the gross margin, which means input costs and prices charged. When margins are at a record, every ratio built on profit looks better than usual, so watch whether they hold. ## Is Vital Farms' profit turning into cash? Over the last 3 years, 103% of Vital Farms, Inc.'s reported profit came in as cash from its operations, so the profit is backed by cash. In FY25 it brought in $33.7 M of operating cash against $66.3 M of profit. After $81.9 M of spending on assets, free cash was −$48.2 M: it spent more than its operations brought in. Cash-flow figures here are yearly, because quarterly cash statements are not published, so this section changes once a year. Why: the cash figure is clear, but the day counts behind it are not in our data, so we show it without guessing the reason. What to look at next: the main use of cash is spending on assets. The next section checks what that spending is building. ## Where does Vital Farms' cash go? Vital Farms, Inc. does not report the customer, stock and supplier day counts a cash cycle needs, so this section looks at its spending on assets instead. It spent $122 M on assets over the last 3 years. Averaged over those years that is 5.4% of FY25 revenue a year. Nothing is estimated in place of the missing day counts, so no cash-cycle chart is drawn. Spending on assets: $122 M over the last 3 years. In short: the cash is going into new capacity, not getting stuck in the daily cycle. The question is whether the new capacity earns. ## What is Vital Farms' P/E ratio, and how does it compare with its own history? Vital Farms, Inc.'s P/E is 2,983.4×, with too little history to compare. This compares the share price with the company’s own past. It does not say what the business is worth. Why the multiple is where it is: over the past year earnings per share moved +22.0% while the price moved −69.7%. Earnings did better than the price, which pulled the multiple down within its own range. In short: there is too little history to say whether the multiple is high or low for this company, so the earnings trend underneath matters more than the multiple. ## Is the Vital Farms business getting better or worse? Vital Farms, Inc.'s business is getting worse. Profit and EPS growth are shrinking: profit growth is −99.7% in the latest quarter, against +1943.6% at its best in 12 quarters, with ROCE falling at 0.1%. This is based on 12 quarters of 4 measures. Why it matters: falling lines mean any ratio below that looks low should be read with that direction in mind. ## How much does Vital Farms earn on its capital? Vital Farms, Inc. earned a ROE of 19% in FY25. That is up from a low of 1% in FY22. Its return on capital used (ROIC) is 16.0 percentage points below its cost of capital, so growth here does not yet pay for the capital it uses. It comes from a 8.7% net margin and 1.46× asset turnover (sales divided by assets). Why the return is what it is (FY25): a 8.7% net margin × 1.46× asset turnover × 1.48× leverage (assets divided by equity) ≈ 18.8% on equity. The margin does its share; borrowing plays a small part, so this return is earned, not borrowed. The key test, return on capital used minus the cost of capital: −8.0% − 8.0% = −16.0 percentage points. The 8.0% is an estimate of this company's own cost of capital. Read the sign and size of the gap, not the decimals. Negative: growth at these returns loses value until returns improve. The −8.0% ROIC above is the latest reading, as reported. The yearly chart below shows FY25 at 30.6%, and the quarterly chart works out each 12-month window from the quarterly figures, so the readings differ by date, not by method. ## Does Vital Farms have too much debt? Vital Farms, Inc. has total debt of $108 M against shareholder equity of $284 M as of Jun 2026, so its debt is 0.38× its equity. Year by year, that ratio went from 0.00 in FY21 to 0.15 in FY25. Keep that borrowing in mind when reading the returns on this page. ## What is the Vital Farms shareholding pattern? 25.7% of Vital Farms, Inc.'s tradable shares are in short positions, which are bets that the price will fall, so a large group of traders is betting against it. At normal trading volumes, closing those positions would take about 4.5 days. US companies do not publish a quarter-by-quarter list of owners, so this page uses short interest instead. It is a single reading at one point in time; we do not have its history. Why it is at this level: the figure does not say who holds the short positions or why, so we show the level without guessing the story. ## How far is Vital Farms from balance-sheet trouble? For Vital Farms, Inc., the Z-score is 3.47. A Z-score above about 3 is safe and below about 1.8 signals danger, so this is well clear of danger. It estimates how far the balance sheet is from trouble; it is not a forecast of failure. Why it matters: a Z-score of 3.47 is well clear of the danger zone, so the balance sheet is not the risk here. ## How does Vital Farms rank in its industry? 33.1 out of 100, rank 10 of 12 in Farm Products, with 71% of the evidence available. Vital Farms, Inc. scores 33.1 out of 100 against the 12 companies it is compared with in Farm Products, ranking 10. The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. The four parts add up to the total exactly: 10.7 + 6.8 + 10 + 5.6 = 33.1. This is the same number shown on the industry page; it is worked out once for the whole group and read here. What would change it: The score would fall if profit growth turns negative or margins stop improving while the share price lags its sector. ## Which companies is Vital Farms compared with? Vital Farms ranks 10 of 12 Farm Products companies on the 4-Factor Sector Score, with 33.1 out of 100. 1. [Village Farms International, Inc.](https://www.sectoralpha.in/us/stocks/vff) VFF · breaking out · Most evidence points up · 71% evidence 69.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 27.2/35 · Revenue 15.5% · Profit 100% · Operating margin change 5.8 points · 83% evidence Capital efficiency 14.1/25 · ROCE 9.8% · Operating margin 17.4% · 76% evidence Valuation 10.9/20 · P/E 10.7× · PEG n/a · 15% evidence Relative strength 17.4/20 · Lead over its industry 7% · Lead over S&P 500 -5% · 1 year -1% · 100% evidence · 11 of 12 weeks ahead Exact sum: 27.2 + 14.1 + 10.9 + 17.4 = 69.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 2. [Alico, Inc.](https://www.sectoralpha.in/us/stocks/alco) ALCO · turning · Evidence leans up · 64% evidence 58.8 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.4/35 · Revenue -61.4% · Profit n/a · Operating margin change 93.2 points · 62% evidence Capital efficiency 18.9/25 · ROCE 71.3% · Operating margin 19.8% · 76% evidence Valuation 8.5/20 · P/E 200.3× · PEG n/a · 15% evidence Relative strength 11.0/20 · Lead over its industry 1% · Lead over S&P 500 -9.3% · 1 year 15.7% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.4 + 18.9 + 8.5 + 11 = 58.8 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 3. [Archer-Daniels-Midland Company](https://www.sectoralpha.in/us/stocks/adm) ADM · quiet · Evidence leans up · 81% evidence 56.2 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 21.6/35 · Revenue -0.8% · Profit 61.1% · Operating margin change 1.8 points · 83% evidence Capital efficiency 13.0/25 · ROCE 5.7% · Operating margin 4% · 76% evidence Valuation 13.3/20 · P/E 20.8× · PEG 0.55 · 65% evidence Relative strength 8.3/20 · Lead over its industry 0.9% · Lead over S&P 500 -8.8% · 1 year 24.4% · 100% evidence · 2 of 12 weeks ahead Exact sum: 21.6 + 13 + 13.3 + 8.3 = 56.2 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 4. [Dole plc](https://www.sectoralpha.in/us/stocks/dole) DOLE · turning · Evidence leans up · 81% evidence 56.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 19.7/35 · Revenue 8.3% · Profit 78.8% · Operating margin change -1.2 points · 83% evidence Capital efficiency 12.2/25 · ROCE 6.2% · Operating margin 2.7% · 76% evidence Valuation 13.7/20 · P/E 21.9× · PEG 0.22 · 65% evidence Relative strength 10.5/20 · Lead over its industry 0.4% · Lead over S&P 500 -10.2% · 1 year 5.3% · 100% evidence · 0 of 12 weeks ahead Exact sum: 19.7 + 12.2 + 13.7 + 10.5 = 56.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 5. [Adecoagro S.A.](https://www.sectoralpha.in/us/stocks/agro) AGRO · quiet · Evidence leans up · 74% evidence 51.3 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 22.1/35 · Revenue 6.3% · Profit 42.9% · Operating margin change 16 points · 62% evidence Capital efficiency 12.2/25 · ROCE 2.6% · Operating margin 17% · 76% evidence Valuation 11.4/20 · P/E 27.5× · PEG 0.65 · 65% evidence Relative strength 5.6/20 · Lead over its industry -6.9% · Lead over S&P 500 -16.4% · 1 year 12.4% · 100% evidence · 2 of 12 weeks ahead Exact sum: 22.1 + 12.2 + 11.4 + 5.6 = 51.3 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 6. [Bunge Global SA](https://www.sectoralpha.in/us/stocks/bg) BG · basing · Evidence leans up · 81% evidence 50.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 20.7/35 · Revenue 80.5% · Profit -26.9% · Operating margin change 1.8 points · 83% evidence Capital efficiency 14.6/25 · ROCE 7.2% · Operating margin 4.6% · 76% evidence Valuation 11.6/20 · P/E 20.6× · PEG 0.7 · 65% evidence Relative strength 3.2/20 · Lead over its industry -9.7% · Lead over S&P 500 -19.1% · 1 year 2.4% · 100% evidence · 0 of 12 weeks ahead Exact sum: 20.7 + 14.6 + 11.6 + 3.2 = 50.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 7. [Tyson Foods, Inc.](https://www.sectoralpha.in/us/stocks/tsn) TSN · turning · Evidence leans down · 71% evidence 47.7 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 12.8/35 · Revenue 2.9% · Profit -26.8% · Operating margin change -1.2 points · 83% evidence Capital efficiency 10.4/25 · ROCE 4.2% · Operating margin 2.7% · 76% evidence Valuation 9.1/20 · P/E 35.9× · PEG n/a · 15% evidence Relative strength 15.4/20 · Lead over its industry 5.9% · Lead over S&P 500 -5.3% · 1 year 14% · 100% evidence · 0 of 12 weeks ahead Exact sum: 12.8 + 10.4 + 9.1 + 15.4 = 47.7 · What this means: Relative strength against the index is -5.3%, and revenue and profit growth are weak. 8. [BrasilAgro - Companhia Brasileira de Propriedades Agrícolas](https://www.sectoralpha.in/us/stocks/lnd) LND · quiet · Most evidence points down · 71% evidence 33.6 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 11.2/35 · Revenue -15.4% · Profit -165% · Operating margin change 13.2 points · 83% evidence Capital efficiency 5.8/25 · ROCE -2.2% · Operating margin -8.1% · 76% evidence Valuation 11.5/20 · P/E -1299.2× · PEG n/a · 15% evidence Relative strength 5.1/20 · Lead over its industry -8.6% · Lead over S&P 500 -18.2% · 1 year -10.1% · 100% evidence · 0 of 12 weeks ahead Exact sum: 11.2 + 5.8 + 11.5 + 5.1 = 33.6 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 9. [Cal-Maine Foods, Inc.](https://www.sectoralpha.in/us/stocks/calm) CALM · basing · Most evidence points down · 85% evidence 33.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 5.2/35 · Revenue -42.5% · Profit -95.4% · Operating margin change -41.3 points · 95% evidence Capital efficiency 9.0/25 · ROCE 0.6% · Operating margin -15.1% · 76% evidence Valuation 16.2/20 · P/E 6× · PEG 0.2 · 65% evidence Relative strength 2.7/20 · Lead over its industry -10% · Lead over S&P 500 -19.5% · 1 year -23.3% · 100% evidence · 1 of 12 weeks ahead Exact sum: 5.2 + 9 + 16.2 + 2.7 = 33.1 · What this means: The valuation scores well, but earnings are not improving yet, so the business does not back up the low multiple so far. 10. Vital Farms, Inc. this page VITL · basing · Most evidence points down · 71% evidence 33.1 out of 100 Growth Capital Valuation Relative How the score adds up Growth & earnings 10.7/35 · Revenue 16.4% · Profit -101.9% · Operating margin change -37.1 points · 83% evidence Capital efficiency 6.8/25 · ROCE 0.1% · Operating margin -24.2% · 76% evidence Valuation 10.0/20 · P/E 21.4× · PEG n/a · 15% evidence Relative strength 5.6/20 · Lead over its industry -35.8% · Lead over S&P 500 -43.9% · 1 year -69.7% · 100% evidence · 2 of 12 weeks ahead Exact sum: 10.7 + 6.8 + 10 + 5.6 = 33.1 · What this means: The evidence is balanced: no factor stands out, so another reported quarter is needed before the picture is clearer. 11. Limoneira Company LMNR · quiet · Most evidence points down · 67% evidence 26.5 out of 100 Growth Capital Valuation Relative
12. [Forafric Global PLC](https://www.sectoralpha.in/us/stocks/afri) AFRI · leader · Too little evidence to rank firmly · 39% evidence 51.8 out of 100 Growth Capital Valuation Relative

Missing figures are not scored as bad. They lower the confidence and pull the final score toward the middle. Relative strength counts only when the company has a reading for this week; with no reading, that factor is left out and its 20 points are shared across the other three in proportion. PEG is not shown when the ratio cannot mean anything: the company must be making a profit, its price-to-earnings must be positive, and its three-year earnings growth must fall between 5% and 60%. Dividing a price multiple by a loss, or by growth measured off a tiny base, produces a number that looks precise and tells you nothing. Under relative strength, one mark per week shows the last 12 weeks: a mark is filled where the company led S&P 500 by 5% or more over the 13 weeks ending that week, which is the same test used everywhere on this site. Price stage places the company on the same six-step path the industry is placed on (basing, turning, breaking out, leader, fading, asleep), read from how many weeks running it has led S&P 500 and whether that lead is growing or shrinking. It describes where the share price stands, not the direction of earnings, and it is not a recommendation; it is left blank for a company whose weekly history is too short or too stale to read. The figures in this ranking come from the industry comparison: results through the Sep 2026 quarter, and the P/E at that quarter's end. The sections above use the latest weekly price, so a P/E or return there can differ a little from the one here. The stage words in this ranking (such as losing its lead or breaking out) describe the lead over the index, not the price phase in the price section. Related companies: [Farm Products](https://www.sectoralpha.in/us/sectors/farm-products), all 12 compared on one page. ## Which companies are close to Vital Farms in size? Vital Farms is the 7th largest of 12 Farm Products companies on Sector Alpha by market value (scores of 4 November 2026). Just above it: Cal-Maine Foods, Inc., Adecoagro S.A. and Dole plc. Just below it: Village Farms International, Inc., Forafric Global PLC and BrasilAgro - Companhia Brasileira de Propriedades Agrícolas. ### Farm Products companies close in size

1. [Cal-Maine Foods, Inc.](https://www.sectoralpha.in/us/stocks/calm) $3.2 billion
2. [Adecoagro S.A.](https://www.sectoralpha.in/us/stocks/agro) $1.3 billion
3. [Dole plc](https://www.sectoralpha.in/us/stocks/dole) $1.3 billion
4. Vital Farms, Inc. $451 million
5. [Village Farms International, Inc.](https://www.sectoralpha.in/us/stocks/vff) $358 million
6. [Forafric Global PLC](https://www.sectoralpha.in/us/stocks/afri) $346 million
7. [BrasilAgro - Companhia Brasileira de Propriedades Agrícolas](https://www.sectoralpha.in/us/stocks/lnd) $329 million

[All 12 Farm Products companies, largest first](https://www.sectoralpha.in/us/sectors/farm-products#all-companies)

### Companies close in size in other industries

1. [Arko Corp.](https://www.sectoralpha.in/us/stocks/arko) $431 million · Specialty Retail
2. [Colony Bankcorp, Inc.](https://www.sectoralpha.in/us/stocks/cban) $430 million · Banks - Regional
3. Vital Farms, Inc. $430 million
4. [Ramaco Resources, Inc.](https://www.sectoralpha.in/us/stocks/metc) $429 million · Coking Coal
5. [Cross Country Healthcare, Inc.](https://www.sectoralpha.in/us/stocks/ccrn) $428 million · Medical Care Facilities

## What else do people ask about Vital Farms? ### What were Vital Farms's latest quarterly results? Vital Farms, Inc. reported revenue of $166 M and a net loss of $31.1 M for the Jun 2026 quarter. Revenue fell 10.1% and profit fell 286.7% compared with a year earlier. Earnings per share were −$0.72. The operating margin was −24.2%, 37.1 percentage points lower than a year earlier (as of 4 November 2026). ### What is Vital Farms's market cap? Vital Farms, Inc.'s market capitalisation is $451 M at a stock price of $10.50. Market cap is the share price times the number of shares, so it changes whenever the price moves (as of 4 November 2026). ### How is Vital Farms performing? Vital Farms, Inc.'s latest readings are below. In its latest quarter, revenue fell 10.1% and profit fell 286.7% compared with a year earlier. Over the past 13 weeks it has done worse than the S&P 500, for 7 weeks running. This describes what the data did, not a rating (as of 4 November 2026). ### Will Vital Farms's stock price go up? This page does not forecast Vital Farms, Inc.'s stock price. What it shows instead: the stock price is $10.50. Nobody can reliably say which way a price will move, and this site does not try (as of 4 November 2026). ### Does Vital Farms have too much debt? Vital Farms, Inc. has a moderate amount of debt: its debt is 0.67× its equity. A year-by-year history of its borrowings is not in our data, so this uses the latest reading. Keep that borrowing in mind when reading the returns on this page (as of 4 November 2026). ### Is Vital Farms's profit real cash? Yes, over the last 3 years, 103% of Vital Farms, Inc.'s reported profit came in as cash from operations. The latest year was lower at 51%, so the trend is worth watching. In FY25, operating cash was $33.7 M against reported profit of $66.3 M. Most of that cash then goes into building new capacity. These are yearly figures (as of 4 November 2026). ### Where is Vital Farms in its business cycle? Vital Farms, Inc.'s FY25 operating margin was 11.6%, against a 5-year range of 0.0% to 11.6%: the top of its range, a record year. When profit is at a record, every ratio looks better than usual, and the story depends on margins staying high. The latest quarter was −24.2%. Comparing margins with a company's own long history is a good way to see where it is in its cycle (as of 4 November 2026). ### What could break the Vital Farms story? The main question: yearly earnings per share moved +22.0% while the share price moved −69.7%. On price, this page treats a rise as over when the share price closes below its 200-day average on two Fridays in a row (as of 4 November 2026). ### Is Vital Farms a stock worth studying right now? What the numbers show: Vital Farms, Inc.'s share price, valuation and earnings point in different directions. The next one or two quarters should make it clearer. The main open question: whether the price catches up with earnings that have already grown. Every number on this page is worked out by code from the published figures, with no forecasts and no price opinions (as of 4 November 2026). This is research, not advice. We’re not SEBI-registered.